HomeCompareHTGM vs EPRT

HTGM vs EPRT: Dividend Comparison 2026

HTGM yields 416.67% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTGM wins by $15446.79M in total portfolio value
10 years
HTGM
HTGM
● Live price
416.67%
Share price
$0.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15446.85M
Annual income
$10,492,957,272.45
Full HTGM calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — HTGM vs EPRT

📍 HTGM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTGMEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTGM + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTGM pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTGM
Annual income on $10K today (after 15% tax)
$35,416.67/yr
After 10yr DRIP, annual income (after tax)
$8,919,013,681.58/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, HTGM beats the other by $8,919,002,766.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTGM + EPRT for your $10,000?

HTGM: 50%EPRT: 50%
100% EPRT50/50100% HTGM
Portfolio after 10yr
$7723.46M
Annual income
$5,246,485,056.58/yr
Blended yield
67.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

HTGM
Analyst Ratings
8
Buy
Consensus: Buy
Price Target
$0.17
-65.3% upside vs current
Range: $0.17 — $0.17
Altman Z
-35.3
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTGM buys
0
EPRT buys
0
No recent congressional trades found for HTGM or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTGMEPRT
Forward yield416.67%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$15446.85M$63.4K
Annual income after 10y$10,492,957,272.45$12,840.73
Total dividends collected$14996.03M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$0.17$35.50

Year-by-year: HTGM vs EPRT ($10,000, DRIP)

YearHTGM PortfolioHTGM Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$52,367$41,666.67$11,205$505.18+$41.2KHTGM
2$259,952$203,920.04$12,672$682.46+$247.3KHTGM
3$1,224,201$946,051.97$14,490$930.48+$1.21MHTGM
4$5,473,698$4,163,802.84$16,786$1,282.69+$5.46MHTGM
5$23,256,265$17,399,408.07$19,753$1,791.56+$23.24MHTGM
6$93,973,351$69,089,147.58$23,677$2,541.64+$93.95MHTGM
7$361,461,534$260,910,048.59$29,008$3,672.99+$361.43MHTGM
8$1,324,680,829$937,916,987.81$36,463$5,425.08+$1324.64MHTGM
9$4,629,809,751$3,212,401,263.77$47,238$8,221.57+$4629.76MHTGM
10$15,446,853,706$10,492,957,272.45$63,385$12,840.73+$15446.79MHTGM

HTGM vs EPRT: Complete Analysis 2026

HTGMStock

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Full HTGM Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this HTGM vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTGM vs SCHDHTGM vs JEPIHTGM vs OHTGM vs KOHTGM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.